Potential benefits of antihypertensive therapy in NAFLD: results from an experimental model
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.2782
Abstract: Non-alcoholic fatty liver disease (NAFLD) is considered as the most frequent cause of chronic hepatic disease in adults. It is strictly correlated with insulin resistance. The renin-angiotensin system (RAS) has been correlated to the whole… read more here.
Keywords: olmesartan ramipril; arterial hypertension; potential benefits; nafld ... See more keywords